Drug Co. Gets OK To Fight Damages In Seroquel MDL
Plaintiffs in multidistrict litigation over AstraZeneca LP's blockbuster drug Seroquel have failed in their attempt to bar the drugmaker from presenting an argument against punitive damages in the first group of...To view the full article, register now.
Already a subscriber? Click here to view full article